Calithera Biosciences (CALA) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CALA Stock Alerts $0.03 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability Calithera Biosciences Short Interest DataCurrent Short Volume366,600 sharesPrevious Short Volume417,300 sharesChange Vs. Previous Month-12.15%Dollar Volume Sold Short$150,306.00Short Interest Ratio / Days to Cover1.2Last Record DateJanuary 31, 2023Outstanding Shares4,870,000 sharesFloat Size4,780,000 sharesShort Percent of Float7.67%Today's Trading Volume583 sharesAverage Trading Volume1,587 sharesToday's Volume Vs. Average37% Short Selling Calithera Biosciences ? Sign up to receive the latest short interest report for Calithera Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCALA Short Interest Over TimeCALA Days to Cover Over TimeCALA Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Calithera Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2023366,600 shares $150,306.00 -12.2%7.7%1.2 $0.41 1/15/2023417,300 shares $219,624.99 +35.0%8.7%1.9 $0.53 12/30/2022309,200 shares $1.01 million +108.2%6.5%1.7 $3.26 12/15/2022148,500 shares $246,510.00 +0.6%3.1%2 $1.66 11/30/2022147,600 shares $287,820.00 +0.3%3.1%2.5 $1.95 11/15/2022147,200 shares $350,336.00 -14.4%3.1%2.2 $2.38 Get the Latest News and Ratings for CALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/31/2022171,900 shares $431,469.00 -7.9%3.6%2.3 $2.51 10/15/2022186,600 shares $464,634.00 +18.9%4.0%2.1 $2.49 9/30/2022156,900 shares $461,286.00 +20.3%3.4%1.5 $2.94 9/15/2022130,400 shares $481,176.00 +6.1%2.8%1.6 $3.69 8/31/2022122,900 shares $478,081.00 -32.3%2.6%1.1 $3.89 8/15/2022181,600 shares $750,916.00 +6.4%3.9%1.4 $4.14 7/31/2022170,700 shares $542,826.00 +18.4%3.7%1.1 $3.18 7/15/2022144,200 shares $376,362.00 -27.2%3.2%0.8 $2.61 6/30/2022198,100 shares $487,326.00 +70.5%4.4%1.1 $2.46 6/15/2022116,200 shares $6.39 million -93.7%3.1%0.6 $55.00 5/31/20221,850,000 shares $379,990.00 -10.2%N/A0.5 $0.21 5/15/20222,060,000 shares $473,800.00 +28.8%N/A0.7 $0.23 4/30/20221,600,000 shares $393,600.00 -37.0%N/A0.7 $0.25 4/15/20222,540,000 shares $787,400.00 +32.3%N/A0.9 $0.31 3/31/20221,920,000 shares $775,680.00 +22.3%2.7%0.9 $0.40 3/15/20221,570,000 shares $712,780.00 +20.8%2.3%1.1 $0.45 2/28/20221,300,000 shares $630,500.00 -2.3%1.9%0.9 $0.49 2/15/20221,330,000 shares $658,483.00 +23.2%1.9%0.8 $0.50 1/31/20221,080,000 shares $702,000.00 +133.7%1.6%0.5 $0.65 1/15/2022462,100 shares $250,458.20 +18.2%0.7%0.2 $0.54 12/31/2021391,100 shares $260,081.50 -36.3%0.6%0.2 $0.67 12/15/2021613,700 shares $435,174.67 -3.0%0.9%0.4 $0.71 11/30/2021632,500 shares $523,457.00 -29.8%0.9%0.4 $0.83 11/15/2021900,900 shares $909,909.00 -58.9%1.3%0.6 $1.01 10/29/20212,190,000 shares $4.23 million +10.6%3.2%1.9 $1.93 10/15/20211,980,000 shares $4.04 million +12.5%2.9%3.7 $2.04 9/30/20211,760,000 shares $3.84 million +7.3%2.6%3.1 $2.18 9/15/20211,640,000 shares $3.44 million -31.7%2.4%2.3 $2.10 8/31/20212,400,000 shares $5.88 million -9.8%3.5%3.3 $2.45 8/13/20212,660,000 shares $6.09 million +35.0%3.9%3.2 $2.29 7/30/20211,970,000 shares $3.84 million -6.6%2.9%2 $1.95 7/15/20212,110,000 shares $4.28 million -3.7%3.1%2.1 $2.03 6/30/20212,190,000 shares $4.58 million -28.4%3.2%2.2 $2.09 6/15/20213,060,000 shares $6.85 million +1.0%4.5%3.5 $2.24SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CALA Short Interest - Frequently Asked Questions What is Calithera Biosciences' current short interest? Short interest is the volume of Calithera Biosciences shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 366,600 shares of CALA short. 7.67% of Calithera Biosciences' shares are currently sold short. Learn More on Calithera Biosciences' current short interest. What is a good short interest ratio for Calithera Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CALA shares currently have a short interest ratio of 1.0. Learn More on Calithera Biosciences's short interest ratio. What is a good short interest percentage for Calithera Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.67% of Calithera Biosciences' floating shares are currently sold short. Is Calithera Biosciences' short interest increasing or decreasing? Calithera Biosciences saw a decline in short interest in January. As of January 31st, there was short interest totaling 366,600 shares, a decline of 12.1% from the previous total of 417,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Calithera Biosciences' float size? Calithera Biosciences currently has issued a total of 4,870,000 shares. Some of Calithera Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Calithera Biosciences currently has a public float of 4,780,000 shares. How does Calithera Biosciences' short interest compare to its competitors? 7.67% of Calithera Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Calithera Biosciences: Aptevo Therapeutics Inc. (5.13%), Allarity Therapeutics, Inc. (9.18%), Aditxt, Inc. (0.99%), China SXT Pharmaceuticals, Inc. (4.78%), Evelo Biosciences, Inc. (2.11%), Neptune Wellness Solutions Inc (0.54%), SciSparc Ltd. (24.15%), Smart for Life, Inc. (15.01%), Motus GI Holdings, Inc. (0.46%), Better Therapeutics, Inc. (8.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.19 billion), Snowflake Inc. ($2.35 billion), T. Rowe Price Group, Inc. ($2.14 billion), Coinbase Global, Inc. ($2.14 billion), Paramount Global ($1.99 billion), Etsy, Inc. ($1.76 billion), Lucid Group, Inc. ($1.70 billion), Wayfair Inc. ($1.63 billion), Old Dominion Freight Line, Inc. ($1.61 billion), and CarMax, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Calithera Biosciences stock? Short selling CALA is an investing strategy that aims to generate trading profit from Calithera Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calithera Biosciences? A short squeeze for Calithera Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CALA, which in turn drives the price of the stock up even further. How often is Calithera Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALA, twice per month. The most recent reporting period available is January, 31 2023. More Short Interest Resources from MarketBeat Related Companies: APVO Short Interest ALLR Short Interest ADTX Short Interest SXTC Short Interest EVLO Short Interest NEPT Short Interest SPRC Short Interest SMFL Short Interest MOTS Short Interest BTTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders